{
  "5NXA.F": {
    "city": "Helsinki",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Nexstim Plc",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NEXSTIM OYJ",
    "state": null,
    "summary": "Nexstim Plc, a neuromodulation company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression order or chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.",
    "website": "http://www.nexstim.com",
    "zipcode": "00510"
  },
  "BONEH.HE": {
    "city": "Oulu",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "HEL",
    "industry": "Medical Devices",
    "long_name": "BBS-Bioactive Bone Substitutes Oyj",
    "market": "fi_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BBS-Bioactive Bone Substitutes",
    "state": null,
    "summary": "BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBON, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins. The company was founded in 2003 and is headquartered in Oulu, Finland.",
    "website": "http://www.bbs-artebone.fi",
    "zipcode": "90220"
  },
  "BONES.ST": {
    "city": "Oulu",
    "country": "Finland",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "BBS-Bioactive Bone Substitutes Oyj",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BBS-Bioactive Bone Substitutes",
    "state": null,
    "summary": "BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBON, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins. The company was founded in 2003 and is headquartered in Oulu, Finland.",
    "website": "http://www.bbs-artebone.fi",
    "zipcode": "90220"
  },
  "NXTMH.HE": {
    "city": "Helsinki",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "HEL",
    "industry": "Medical Devices",
    "long_name": "Nexstim Plc",
    "market": "fi_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Nexstim Oyj",
    "state": null,
    "summary": "Nexstim Plc, a neuromodulation company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression order or chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.",
    "website": "http://www.nexstim.com",
    "zipcode": "00510"
  },
  "NXTMS.ST": {
    "city": "Helsinki",
    "country": "Finland",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Nexstim Plc",
    "market": "se_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Nexstim Oyj",
    "state": null,
    "summary": "Nexstim Plc, a neuromodulation company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression order or chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.",
    "website": "http://www.nexstim.com",
    "zipcode": "00510"
  },
  "OPTOMED.HE": {
    "city": "Oulu",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "HEL",
    "industry": "Medical Devices",
    "long_name": "Optomed Oyj",
    "market": "fi_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Optomed Plc",
    "state": null,
    "summary": "Optomed Oyj, a medical technology company, provides handheld fundus cameras and eye-screening devices in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. It offers handheld fundus camera products, which are used in ophthalmology, pediatric care, endocrinology, neurology, and primary care. Its product portfolio consists of Optomed Smartscope Pro, Optomed Aurora, and Optomed Aava, as well as OEM cameras, including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal; and desktops cameras, such as Optomed Polaris tabletop fundus cameras and Optomed Halo portable retinal cameras. The company also provides Optomed Avenue, a Software-as-a-Service (SaaS) platform that offers access to artificial intelligence services, screening process management tools, and remote image analyses; Avenue Eye Screen, a workflow management system for screening and monitoring of eye diseases, such as diabetic retinopathy; Avenue Telemedicine, a remote analysis solution for faster access to medical consultation; Avenue Viewer, a patient data management solution for viewing, reporting, and archiving fundus images; and Avenue Sync, a software solution. In addition, it offers process management software for various cancer screenings; radiology information system, a software system for healthcare imaging units for managing medical images and associated data; and solution for digital pathology. Further, the company provides professional IT consulting services for government institutions. It sells its products and solutions through OEMs, distributors, and direct sales. The company's customers include hospitals, eye clinics, and optician chains and stores. The company was founded in 2004 and is headquartered in Oulu, Finland.",
    "website": "http://www.optomed.com",
    "zipcode": "90230"
  },
  "R0V.MU": {
    "city": "Vantaa",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "MUN",
    "industry": "Medical Devices",
    "long_name": "Revenio Group Oyj",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "REVENIO GROUP CORP. EO 15",
    "state": null,
    "summary": "Revenio Group Oyj, a health technology company, designs, manufactures, and sells medical instruments for the early detection of glaucoma, diabetic retinopathy, and macular degeneration in Finland, Italy, rest of Europe, the United States, and internationally. The company offers ic100 and ic200 tonometers; Icare HOME, a device for self-measurement of eye pressure; Icare TONOVET Plus tonometers for animals; fundus imaging devices comprising EIDON, DRS, and DRSplus; MAIA, a microperimeter to measure the effectiveness of drugs for retinal disease treatment; COMPASS, which provides fundus perimetry with true-color confocal retinal images; and Ventica, to examine the variability in tidal breathing in children. It is also developing Cutica, a hyperspectral camera for dermatologists to detect skin cancers. Revenio Group Oyj is based in Vantaa, Finland.",
    "website": "http://www.reveniogroup.fi",
    "zipcode": "01510"
  },
  "REG1V.HE": {
    "city": "Vantaa",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "HEL",
    "industry": "Medical Devices",
    "long_name": "Revenio Group Oyj",
    "market": "fi_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Revenio Group Corporation",
    "state": null,
    "summary": "Revenio Group Oyj, a health technology company, designs, manufactures, and sells medical instruments for the early detection of glaucoma, diabetic retinopathy, and macular degeneration in Finland, Italy, rest of Europe, the United States, and internationally. The company offers ic100 and ic200 tonometers; Icare HOME, a device for self-measurement of eye pressure; Icare TONOVET Plus tonometers for animals; fundus imaging devices comprising EIDON, DRS, and DRSplus; MAIA, a microperimeter to measure the effectiveness of drugs for retinal disease treatment; COMPASS, which provides fundus perimetry with true-color confocal retinal images; and Ventica, to examine the variability in tidal breathing in children. It is also developing Cutica, a hyperspectral camera for dermatologists to detect skin cancers. Revenio Group Oyj is based in Vantaa, Finland.",
    "website": "http://www.reveniogroup.fi",
    "zipcode": "01510"
  }
}
